Company: PHAT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-104548
Chunk: 9

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 6
Chunk 9
---
 10-Q
      
     5/10/23
      
     4.6

     4.7
      
     Note Purchase Agreement, dated May 7, 2019, by and among the Registrant and the other parties party thereto, as amended
      
     S-1/A
      
     10/15/19
      
     4.5

     4.8
      
     Form of Pre-Funded Warrant to purchase common stock
      
     8-K
      
     8/19/24
      
     4.1

     10.1#
      
     Separation Agreement and Release of Claims, dated May 18, 2025, by and between Azmi Nabulsi, M.D., M.P.H. and the Registrant 

     X 

     10.2#
      
     Separation Agreement and Release of Claims, dated May 20, 2025, by and between Molly Henderson and the Registrant 

     X 

     10.3#
      
     Employment Letter Agreement, dated June 4, 2025, by and between Anne Marie Cook and the Registrant

     X

     31.1
       
     Certification of Chief Executive Officer of Phathom Pharmaceuticals, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

     X

     31.2
       
     Certification of Chief Financial Officer of Phathom Pharmaceuticals, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

     X

     32.1*
       
     Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     X

     32.2*
       
     Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     X

     101.INS
      
     Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document

     X